
The DTE Mess, Pharmacy Board Shenanigans, and GLP-1 Confusion | Essential: Pharmacy Compounding Podcast APC
About this episode
This episode of Essential unpacks FDA confusion, California’s latest compounding curveball, and pharma-fueled myths about GLP-1s. We spotlight APC’s advocacy wins on Capitol Hill and why pharmacy tours pack political punch. Plus, the FDA’s eyebrow-raising move to reclassify natural thyroid products — and why it matters for patients everywhere. News item about California reg: https://a4pc.org/news/this-one-little-word-could-trip-you-up Compounding primer: https://join.a4pc.org/hubfs/PDFs/Traditional-Pharmacy-Compounding-101.pdf?hsLang=en APC’s guide to hosting a legislator: https://join.a4pc.org/hubfs/PDFs/2021-04_APC-Guidance-Hosting-Pharmacy-Visits.pdf APC in the News: https://a4pc.org/inthenews DTE grassroots campaign: https://compounding.com/thyroid
Get every episode summarized
Each time Pharmacy Podcast Network publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Pharmacy Podcast Network

Thug Drugs: Psychedelic Studies | Pain Pod
Pharmacy Podcast Network

Beyond Dispensing: Building a Pharmacy Around Medication Management and Communit...
Pharmacy Podcast Network

More Patients, Same Pharmacists: Preparing Independent Pharmacy for the Next Era...
Pharmacy Podcast Network

Inventory, AI and Automation, R&D Tax Credits, Peptides, and Basis | The Bottom...
Pharmacy Podcast Network